PathAI Receives FDA Clearance for AISight Dx Platform
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
